TLR9 and systemic lupus erythematosus: The pathogenic effects of NETs in psoriasis (75) and SLE (76, 77) have been attributed to their stimulatory activity on pDCs, wherein nucleic acid-mediated TLR9/7 stimulation causes type I IFN secretion, which in turn potentiates the autoinflammatory loop (76–78).